Savera Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.90 Cr
as on 16-11-2024
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.08 Cr
as on 16-11-2024
- Satisfied Charges ₹ 27.15 Cr
as on 16-11-2024
- Revenue 19.17%
(FY 2023)
- Profit 86.78%
(FY 2023)
- Ebitda 180.47%
(FY 2023)
- Net Worth -1.36%
(FY 2023)
- Total Assets 0.45%
(FY 2023)
About Savera Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.90 Cr.
The company currently has active open charges totaling ₹10.08 Cr. The company has closed loans amounting to ₹27.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ajit Save, Anil Save, Rajeev Churi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1996PTC097697
- Company No.
097697
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Savera Pharmaceuticals Private Limited offer?
Savera Pharmaceuticals Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Common Disease Medicines, Pharmaceutical Medicine, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Psychotherapeutic Agents, Pharmaceutical Tablets.
Who are the key members and board of directors at Savera Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Churi  | Director | 27-Feb-1996 | Current |
| Ajit Save | Director | 27-Feb-1996 | Current |
| Anil Save | Director | 27-Feb-1996 | Current |
| Arpit Save | Additional Director | Current | |
| Anjali Save | Director | 30-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Savera Pharmaceuticals.
Savera Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.17% increase. The company also saw a substantial improvement in profitability, with a 86.78% increase in profit. The company's net worth dipped by a decrease of 1.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Savera Pharmaceuticals?
Unlock access to Savera Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Savera Carriers And Contractors Private LimitedActive 45 years 6 monthsAjit Save is a mutual person
Sarbi Engineering And Ware Housng Private LimitedActive 46 years 7 monthsRajeev Churi is a mutual person
North Konkan Chamber Of Commerce And Agricultural FoundationActive 10 years 11 monthsRajeev Churi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Sep 2024 | ₹3.23 M | Open |
Others Creation Date: 31 Oct 2019 | ₹3.00 Cr | Open |
Others Creation Date: 14 Jan 2019 | ₹1.63 Cr | Open |
How Many Employees Work at Savera Pharmaceuticals?
Unlock and access historical data on people associated with Savera Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Savera Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Savera Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
